BILLS-110hr2900ih.pdf

VerDate Aug 31 2005 03:24 Jun 29, 2007 2007 annual fiscal year 30 days later than 180 days later than 30 days 2012 fiscal year 2009 fiscal year 2008 30-day such fiscal year a fiscal year six months fiscal year 2007 each fiscal year later than 1 year later than 90 days later than 120 days 15 days 180-day 2009 fiscal year 2012 the next fiscal year October 1, 2007 fiscal years annually later than 60 days 17 year 20 days 12-month fiscal year 2011 fiscal year 2010 later than 5 days 2 year 2003 October 1, 2012 the fiscal year each year one year later than one year 2 years the first fiscal year 1 year 6 fiscal years 14 days October 1 1986

the ‘‘Pediatric Research the ‘‘Pediatric Medical the ‘‘Act the ‘‘Food and Drug the ‘‘Best Pharmaceuticals the ‘‘Administra- 16

502(4

2900 IH United States the United States Pediatric the District of Columbia the United States of America U.S. Founda- Texas Georgia 2900 IH cal year 16 States CONTENTS.—A Michigan Tennessee Treas- the District of Columbia Circuit 2900 IH ple Orphan 2900 IH Pediatric Advisory Committee 2900 IH ent 2900 IH Pensions 2900 IH year

appro- 4 appro- 16

Cosmetic 510(k FUNDING.—The APPROPRIATIONS.—To Indian

SEC the Federal Food, Drug U.S.C. the Food and Drug Administration Congress NIH Food and Drug Administration Foundation Drug Administration the Public Health Service Act DTC Federal Food and Drugs Board Senate Health and Human Services the Federal Register the Food and Drug Administra- Labor Food, Drug the Pediatric Advisory Committee GENERAL.—If the House of Representatives the Committee on Energy Federal Food, Drug the Federal Food Food Office the Best Pharmaceuticals for Children Act the Committee on Health, Education the Best Pharmaceuticals the National Institutes of Health State National Institutes of Health uct United Drug Federal Register the Drug Safety Oversight Board the Commissioner of Food and Drugs the Committee on Health the Food and Drug Admin- the Commissioner of Food -Udall Foundation the Food and Drug the Pediatric Advisory Health House Healthcare Research and Quality Best Pharmaceuticals

Reagan SIBLE.—If mary BARROW Subparagraph GENE GREEN RUSH ting INSLEE BURGESS ALLEN UPTON CAPPS FERGUSON ROSS BUTTERFIELD BARTON BONO GORDON MATHESON HOOLEY WAXMAN MELANCON PALLONE DEGETTE ENGEL ESHOO MYRICK SCHAKOWSKY TERRY MARKEY DINGELL

postmarket user fee pediatric drugs medical devices fee amendments drugs sec clinical trial food drug drug user device medical device prescription devices sec